Farmacéuticos Comunitarios. 2018 Mar 30; 10(1):47-49 DOI: 10.5672/FC.2173-9218.(2018/Vol10).001.07
Possible link of loratadine with a fatal outcome in an at-risk patient
Pol E, Mirch R, Mayoral E, Martínez P. Posible relación de loratadina con el desenlace fatal en un paciente de riesgo. Farmacéuticos Comunitarios. 2018 Mar 30; 10 (1): 47-49 DOI: 10.5672/FC.2173-9218.(2018/Vol10).001.07
Abstract :
A 69-year-old man, who has been clinically chronic for severe and persistent mental illness, COPD, diabetes and hypothyroidism, stabilized for several months, began treatment with loratadine for rhinitis. The next day he is found unconscious and rushed to the general hospital for intensive care, where he dies a day later. The case analysis reveals a possible “butterfly effect,” a fatal outcome caused by a low-risk drug, given the “borderline” situation of prior therapy.
Keywords :
Loratadine, ventricular arrhythmias, death, mental illness, butterfly effect
Article download link:
Última actualización de farmaceuticoscomunitarios.org : 29.03.2018
Copyright © 2012-2014 SEFAC (Sociedad Española de Farmacia Comunitaria) |
ISSN Digital edition: 2173-9218
Journal committees - Privacy policy - Cookies policy - Advertising policy
e-mail: soporte@sefac.org | Responsible for this web site: Jordi Serrano Valdés
Development, Web design & computer programming: Edittec |
We subscribe to
HONcode principles. Check it out here.
The information provided on this site is intended to complement and not to replace the
relation between a patient and his or her existing physician.
This work is under Creative Commons licence Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional licence.